3 results
Approved WMOCompleted
Investigating the bioequivalence of the new formulation of escitalopram.
Approved WMOCompleted
The overall objectives of the iSPOT-D trial are to use standardised genetic-brain-cognitionprotocols to:1. Identify markers of MDD as a diagnostic group and its subtypes2. Identify markers which change with acute (8 weeks) drug treatment in MDD3.…
Approved WMOCompleted
Investigating the bioequivalence of the new formulation of escitalopram.